Author： Lary J.M. Daniel K.L. Erickson J.D. Roberts H.E. Moore C.A.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.21, Iss.3, 1999-09, pp. : 161-169
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Does Thalidomide Cause Second Generation Birth Defects?
By Smithells D.
Drug Safety, Vol. 19, Iss. 5, 1998-11 ,pp. :
Access to resources
Recommend
Thalidomide in Cancer Treatment: A Potential Role in the Elderly?
By Zhou S.
Drugs & Aging, Vol. 19, Iss. 2, 2002-02 ,pp. :
Thalidomide - most significant drug in decades for multiple myeloma?
Inpharma, Vol. 1, Iss. 1225, 2000-01 ,pp. :
Thalidomide addition a paradigm shift for newly diagnosed MM?
Inpharma, Vol. 1, Iss. 1547, 2006-01 ,pp. :
The return of Tysabri to the market in the US?
Inpharma, Vol. 1, Iss. 1529, 2006-01 ,pp. :